Compounds for the treatment of dementia related diseases

摘要

The present invention relates to new compounds of formula (I) wherein Y, P, R¹, R², R³, n, m are defined as in claim 1 , a process for their preparation and new intermediates used therein, pharmaceutical composition containing said therapeutically active compounds and to the use of said active compounds in therapy, especially in the prevention and/or treatment of dementia related disease, Alzheimer's Disease and conditions associated with glycogen synthase kinase-3